Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03184571
Title BGB324 in Combination With Pembrolizumab in Patients With Advanced NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BerGenBio ASA
Age Groups: senior | adult
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756 United States Details
Medical College of Wisconsin, 9200 W Wisconsin Avenue Milwaukee Wisconsin 53226-3522 United States Details
Radiumhospitalet, Oslo University Hospital PB Oslo 0424 Norway Details
Hospital Universitari Germans Trias i Pujol-ICO Barcelona Badalona 08916 Spain Details
Servicio de Oncologia Hospital del Mar Barcelona 08003 Spain Details
Hospital Universitario Vall d'Hebron (VHIR) Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
Hospital Teresa Herrera Coruna 15006 Spain Details
Hospital Universitario Fundacion Jimene Diaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre, Servicio de oncologia Madrid 28041 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
Guy's and St Thomas' NHS Foundation Trust London SE1 9RT United Kingdom Details
Christie NHS Hospital Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from for the field